IRIS Accounts Production v26.1.10.61 08260548 Board of Directors 1.2.25 31.1.26 31.1.26 false true false false true false 214108 131191 181030 137454 88883 54537 306255 214108 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh082605482025-01-31082605482026-01-31082605482025-02-012026-01-31082605482024-01-31082605482024-02-012025-01-31082605482025-01-3108260548ns15:EnglandWales2025-02-012026-01-3108260548ns14:PoundSterling2025-02-012026-01-3108260548ns10:Director12025-02-012026-01-3108260548ns10:PrivateLimitedCompanyLtd2025-02-012026-01-3108260548ns10:SmallEntities2025-02-012026-01-3108260548ns10:AuditExempt-NoAccountantsReport2025-02-012026-01-3108260548ns10:SmallCompaniesRegimeForDirectorsReport2025-02-012026-01-3108260548ns10:SmallCompaniesRegimeForAccounts2025-02-012026-01-3108260548ns10:FullAccounts2025-02-012026-01-310826054842ns10:Director22025-01-310826054842ns10:Director22024-01-310826054842ns10:Director22025-02-012026-01-310826054842ns10:Director22024-02-012025-01-310826054842ns10:Director22026-01-310826054842ns10:Director22025-01-3108260548ns10:Director22025-02-012026-01-3108260548ns10:Director32025-02-012026-01-3108260548ns10:Director42025-02-012026-01-3108260548ns10:Director52025-02-012026-01-3108260548ns10:Director62025-02-012026-01-3108260548ns10:RegisteredOffice2025-02-012026-01-3108260548ns5:CurrentFinancialInstruments2026-01-3108260548ns5:CurrentFinancialInstruments2025-01-3108260548ns5:ShareCapital2026-01-3108260548ns5:ShareCapital2025-01-3108260548ns5:RetainedEarningsAccumulatedLosses2026-01-3108260548ns5:RetainedEarningsAccumulatedLosses2025-01-3108260548ns5:LandBuildings2025-01-3108260548ns5:MotorVehicles2025-01-3108260548ns5:ComputerEquipment2025-01-3108260548ns5:LandBuildings2025-02-012026-01-3108260548ns5:MotorVehicles2025-02-012026-01-3108260548ns5:ComputerEquipment2025-02-012026-01-3108260548ns5:LandBuildings2026-01-3108260548ns5:MotorVehicles2026-01-3108260548ns5:ComputerEquipment2026-01-3108260548ns5:LandBuildings2025-01-3108260548ns5:MotorVehicles2025-01-3108260548ns5:ComputerEquipment2025-01-3108260548ns5:CostValuation2025-01-3108260548ns5:AdditionsToInvestments2026-01-3108260548ns5:CostValuation2026-01-3108260548ns5:WithinOneYearns5:CurrentFinancialInstruments2026-01-3108260548ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3108260548ns10:Director112025-01-3108260548ns10:Director112024-01-3108260548ns10:Director112025-02-012026-01-3108260548ns10:Director112024-02-012025-01-3108260548ns10:Director112026-01-3108260548ns10:Director112025-01-31
REGISTERED NUMBER: 08260548 (England and Wales)







UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2026

FOR

OB/GYN LEGAL LTD

OB/GYN LEGAL LTD (REGISTERED NUMBER: 08260548)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


OB/GYN LEGAL LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2026







DIRECTORS: Mr D Irons
Mrs D Irons
Miss G Irons
Mr E Irons
Mr O W Irons
Mr N J Cato





REGISTERED OFFICE: 2 Crewe Street
Seahouses
Northumberland
NE68 7RW





REGISTERED NUMBER: 08260548 (England and Wales)

OB/GYN LEGAL LTD (REGISTERED NUMBER: 08260548)

BALANCE SHEET
31 JANUARY 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 3 308,741 332,539
Investments 4 80,500 58,625
389,241 391,164

CURRENT ASSETS
Debtors 5 633,625 462,634
Cash at bank 455,777 467,196
1,089,402 929,830
CREDITORS
Amounts falling due within one year 6 176,228 158,417
NET CURRENT ASSETS 913,174 771,413
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,302,415

1,162,577

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 1,302,215 1,162,377
1,302,415 1,162,577

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

OB/GYN LEGAL LTD (REGISTERED NUMBER: 08260548)

BALANCE SHEET - continued
31 JANUARY 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 July 2026 and were signed on its behalf by:





Mr D Irons - Director


OB/GYN LEGAL LTD (REGISTERED NUMBER: 08260548)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026

1. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

RELATED PARTY EXEMPTION
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

TURNOVER
The turnover shown in the profit and loss account represents amount earned during the year and is recognised when the company obtains the right to consideration.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

All fixed assets are initially recorded at cost.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2025 - 6 ) .

OB/GYN LEGAL LTD (REGISTERED NUMBER: 08260548)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

3. TANGIBLE FIXED ASSETS
Freehold Motor Computer
property vehicles equipment Totals
£    £    £    £   
COST
At 1 February 2025 232,183 128,105 18,096 378,384
Additions - - 1,722 1,722
At 31 January 2026 232,183 128,105 19,818 380,106
DEPRECIATION
At 1 February 2025 - 32,026 13,819 45,845
Charge for year - 24,020 1,500 25,520
At 31 January 2026 - 56,046 15,319 71,365
NET BOOK VALUE
At 31 January 2026 232,183 72,059 4,499 308,741
At 31 January 2025 232,183 96,079 4,277 332,539

4. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 February 2025 58,625
Additions 21,875
At 31 January 2026 80,500
NET BOOK VALUE
At 31 January 2026 80,500
At 31 January 2025 58,625

OB/GYN LEGAL LTD (REGISTERED NUMBER: 08260548)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 230,017 188,789
Other debtors 5,000 5,000
CT Debtor 52,891 52,891
Estate of S Bousetad 39,129 -
Directors' current accounts 306,255 214,108
Prepayments and accrued income 333 1,846
633,625 462,634

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Tax 116,449 108,402
VAT 45,111 32,710
Credit Card 8,414 13,914
Accrued expenses 6,254 3,391
176,228 158,417

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 January 2026 and 31 January 2025:

2026 2025
£    £   
Mr D Irons and Mrs D Irons
Balance outstanding at start of year 214,108 131,191
Amounts advanced 181,030 137,454
Amounts repaid (88,883 ) (54,537 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 306,255 214,108